Latest Manufacturing News

InhaleRx has secured swift Human Research Ethics Committee approval for its redesigned IRX-211 Phase 2 trial, expanding participant numbers and potentially bypassing Phase 3 to speed market entry.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

AdAlta Limited has successfully raised $1.1 million through a renounceable rights issue, positioning itself to advance key CAR-T licensing and immunotherapy projects. The capital injection underscores confidence from leadership and investors amid a transformative phase for the biotech company.

Everest Metals Corporation has completed a breakthrough engineering study demonstrating 97% rubidium recovery at its Mt Edon project, advancing Australia’s entry into the global rubidium market with a patented extraction process.

Paradigm Biopharmaceuticals has reached key milestones in its global Phase 3 trial for knee osteoarthritis, activating its first Australian clinical site and enrolling the first patient. With multiple sites in Australia and the US preparing for recruitment, the trial is advancing steadily toward critical data readouts.

ReNerve Limited has entered a strategic partnership with Berkeley Biologics to develop and commercialise two new tissue-based product ranges, aiming to expand its footprint in the US surgical market by the end of 2025.

DXN Limited has secured a significant A$4.6 million contract to deliver three modular data centre units to Globalstar, marking a strategic expansion into satellite communications infrastructure.

Green Critical Minerals has raised A$7 million through an institutional placement to accelerate the commercial rollout of its Very High Density graphite technology, aiming for first revenue in early 2026.

EVE Health Group has initiated stability testing for its novel oral treatments targeting erectile dysfunction and dysmenorrhea, marking a crucial step toward regulatory approval in Australia. The company also finalizes its acquisition of Nextract, the developer behind these innovative formulations.

Metal Powder Works has doubled its production capacity for advanced metal powders using its patented DirectPowder™ process, achieving this milestone without additional capital expenditure. The company also cut production cycle times by up to 40%, positioning itself as a key US supplier for defence applications.

DUG Technology has secured its inaugural commercial lease for the DUG Nomad, a cutting-edge mobile immersion cooling system, marking a key milestone in its edge computing ambitions.

Mayfield Group Holdings has agreed to acquire BE Switchcraft for $7 million, enhancing its manufacturing footprint and product range in energy management and automation. The deal positions Mayfield as a stronger player in Australia's electrical infrastructure market.